Psychiatrist Scottsdale
  • Home
  • About the Psychiatrist
  • Scheduling
  • Rates
  • Contact
  • Insurance Reimbursement
  • Ketamine Scottsdale
  • Adult ADHD Scottsdale
  • Depression Treatment
  • Anxiety Scottsdale Phoenix
  • OCD treatment Scottsdale
  • PTSD Scottsdale
  • why no insurance
  • ONLINE APPOINTMENTS
  • Privacy Practices Phoenix
  • Scottsdale Phoenix appointments
  • billing
  • Psych Info Articles
  • Substance Addiction programs, residential Treatment Resources
  • Emergency Phoenix Psychiatric Resources
  • Finding the right Psychiatrist
  • New Patient Scheduling
  • Adult ADHD Scottsdale

Depression Treatments

Depression Treatment in Scottsdale | Phoenix

Our Scottsdale clinic provides advanced, evidence-based care for individuals struggling with depression. We specialize in personalized depression treatment, combining psychotherapy, lifestyle strategies, and depression medication to help patients regain stability and well-being. From first-line SSRIs to treatment resistant options like ketamine. Dr DePalma  designs treatment plans tailored to your needs.

Recognizing the Symptoms of Depression

Symptoms of depression may include:
  • Persistent sadness or loss of interest in daily life
  • Low energy and fatigue
  • Difficulty concentrating or making decisions
  • Changes in appetite or sleep patterns
  • Feelings of guilt, hopelessness, or worthlessness
  • Physical symptoms such as aches, slowed movements, or digestive issues
  • Suicidal thoughts or self-harm urges
If these symptoms of depression are interfering with your ability to function, professional evaluation is the first step toward recovery.
Picture
Depression Medication Options in Scottsdale | Phoenix
Medication is often an important part of depression treatment. Our providers carefully evaluate each patient before prescribing antidepressants, considering both effectiveness and potential side effects.

Selective Serotonin Reuptake Inhibitors (SSRIs) – First-line treatment for depression that works by increasing serotonin in the brain:
  • Prozac (Fluoxetine)
  • Lexapro (Escitalopram / Escitalopram oxalate)
  • Zoloft (Sertraline)
  • Celexa (Citalopram hydrobromide)
  • Paxil (Paroxetine)
*Though all medications in this class share the same core mechanism of serotonin reuptake inhibition, each SSRI has unique pharmacological differences. These include varying levels of affinity for additional transporters and serotonin receptor subtypes, distinct effects on metabolic enzymes in the liver, and differences in absorption and elimination rates. As a result, each medication can present meaningful variations in onset of action, tolerability, subjective effects, and side effect profiles.
For example, some SSRIs may be more activating and better suited for patients with low energy, while others have calming properties that may benefit those with anxiety or sleep disturbances. Additionally, drug-drug interactions can vary significantly between SSRIs, making personalized medication selection essential for both safety and effectiveness.

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs):
  • Effexor (Venlafaxine hydrochloride)
  • Cymbalta (Duloxetine)
  • Pristiq (Desvenlafaxine)
*As with the class of SSRIs, the SNRI class also has has unique pharmacological differences between them just as with the SSRI class above, resulting in  meaningful variations in onset of action, tolerability, subjective effects, and side effect profiles.

Atypical Antidepressants:
  • Bupropion (Wellbutrin) – Often helpful for fatigue and low motivation.
  • Mirtazapine (Remeron) – Can improve sleep and appetite.
  • Vortioxetine (Trintellix) – May enhance cognition in addition to mood.
  • Vilazodone (Viibryd) – Combines SSRI effects with partial serotonin receptor activity.
  • Trazodone – Frequently used at low doses for insomnia related to depression.
*The medications in this group are even more diverse from one another than those in the previous categories. Not only do they differ in their effects on neurotransmitter transporters, receptor subtypes, metabolic enzymes, and in their absorption and elimination profiles, but they also vary in the primary mechanisms by which they exert antidepressant effects.
For example, Bupropion primarily targets dopamine and norepinephrine pathways rather than serotonin, which can make it more energizing. Mirtazapine works by blocking certain serotonin and histamine receptors, often improving sleep and appetite. Trazodone is most effective at low doses for insomnia due to its sedating properties, while Vortioxetine and Vilazodone combine serotonin reuptake inhibition with unique receptor activity, which may impact cognition and tolerability differently than SSRIs or SNRIs.
This diversity makes atypical antidepressants particularly useful when tailoring depression treatment to individual symptom profiles and tolerability needs.


Tricyclic Antidepressants (TCAs):
  • Amitriptyline
  • Nortriptyline
  • Imipramine
  • Desipramine
  • Clomipramine
  • Doxepin
*While all TCAs share the ability to block the reuptake of serotonin and norepinephrine, they differ significantly in their secondary pharmacological actions. Each medication has distinct binding affinities for histamine, muscarinic (acetylcholine), and adrenergic receptors, which leads to notable differences in side effect profiles, tolerability, and therapeutic applications.Because of their broader receptor activity, TCAs can be highly effective but are often limited by side effects such as weight gain, dry mouth, constipation, blurred vision, and cardiovascular effects (e.g., orthostatic hypotension or arrhythmia risk). As a result, they are usually reserved for patients who do not respond to SSRIs, SNRIs, or atypical antidepressants.


Monoamine Oxidase Inhibitors (MAOIs):
Effective for treatment-resistant depression, but require dietary restrictions and careful monitoring.
MAOIs are among the earliest classes of antidepressants, working by inhibiting the enzyme monoamine oxidase, which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine. By reducing this breakdown, MAOIs increase the availability of these neurotransmitters in the brain.
While highly effective—particularly in cases of atypical or treatment-resistant depression—MAOIs differ from other classes in both their mechanism and their safety considerations. Because they strongly influence multiple neurotransmitter systems, they are associated with dietary restrictions (to avoid hypertensive crisis from tyramine-containing foods) and significant drug-drug interaction risks.



Ketamine Therapy for TRD: Intravenous ketamine is available for individuals with treatment-resistant depression. Research shows rapid symptom relief, often within hours, for patients who have not improved with conventional antidepressants. These treatments can be life-changing, though cost and insurance coverage can present challenges. ​
FOR INFO ABOUT IM KETAMINE TREATMENT AT OUR CLINIC CLICK HERE:
Ketamine Treatment
Therapy & Integrated Care
Medication works best when combined with psychotherapy and lifestyle interventions. We offer:
  • Cognitive Behavioral Therapy (CBT)
  • Mindfulness-based therapy
  • Supportive counseling
  • Sleep and nutrition optimization strategies

Your Scottsdale Resource for Depression Care
Dr DePalma is dedicated to providing compassionate, customized treatment for depression. Whether you’re exploring SSRIs for the first time, need help adjusting medications like Prozac or Lexapro, or are considering treatment resistant options, we’re here to guide you every step of the way.

Get Help Today
If you are experiencing symptoms of depression, don’t wait to seek help. Contact our Scottsdale clinic to schedule a comprehensive evaluation and explore the full range of depression treatments available—from SSRIs to cutting-edge therapies for treatment-resistant depression.